Sofie Biosciences Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
320
- Latest Deal Type
-
M&A
- (Announced)
- Financing Rounds
-
14
- Investments
-
1
Sofie Biosciences General Information
Description
Developer of molecular imaging probes and devices designed to offer radiopharmaceutical products for Vivo research purposes. The company's devices help physicians to search throughout the body for tumors that will respond to drugs that target dCK, enabling caregivers to get access to theragnostic and innovative technologies for personalized healthcare and for more patient-specific treatment selection.
Contact Information
Website
www.sofie.comCorporate Office
- 21000 Atlantic Boulevard
- Suite 730
- Dulles, VA 20166
- United States
Corporate Office
- 21000 Atlantic Boulevard
- Suite 730
- Dulles, VA 20166
- United States
Sofie Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sofie Biosciences Comparisons
Industry
Financing
Details
Sofie Biosciences Competitors (2)
One of Sofie Biosciences’s 2 competitors is Bamf Health, a Venture Capital-Backed company based in Grand Rapids, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bamf Health | Venture Capital-Backed | Grand Rapids, MI | ||||
| Alpha-9 Oncology | Venture Capital-Backed | Vancouver, Canada |
Sofie Biosciences Patents
Sofie Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10589250-B2 | Automated purification and formulation device for radiopharmaceutical compounds | Active | 07-Sep-2016 | ||
| US-20180065103-A1 | Automated purification and formulation device for radiopharmaceutical compounds | Active | 07-Sep-2016 | ||
| EP-3151751-A1 | Self-shielded, benchtop chemistry system | Inactive | 06-Jun-2014 | ||
| EP-3151751-A4 | Self-shielded, benchtop chemistry system | Inactive | 06-Jun-2014 | ||
| US-20170102391-A1 | Self-shielded, benchtop chemistry system | Active | 06-Jun-2014 | G01N33/60 |
Sofie Biosciences Signals
Sofie Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sofie Biosciences Investments (1)
Sofie Biosciences’s most recent deal was a Corporate Asset Purchase with Cyclotope Radiopharmacy. The deal was made on 17-Jun-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cyclotope Radiopharmacy | 17-Jun-2019 | Corporate Asset Purchase | Buildings and Property |
Sofie Biosciences FAQs
-
When was Sofie Biosciences founded?
Sofie Biosciences was founded in 2008.
-
Where is Sofie Biosciences headquartered?
Sofie Biosciences is headquartered in Dulles, VA.
-
What is the size of Sofie Biosciences?
Sofie Biosciences has 320 total employees.
-
What industry is Sofie Biosciences in?
Sofie Biosciences’s primary industry is Diagnostic Equipment.
-
Is Sofie Biosciences a private or public company?
Sofie Biosciences is a Private company.
-
What is the current valuation of Sofie Biosciences?
The current valuation of Sofie Biosciences is .
-
What is Sofie Biosciences’s current revenue?
The current revenue for Sofie Biosciences is .
-
How much funding has Sofie Biosciences raised over time?
Sofie Biosciences has raised $505M.
-
Who are Sofie Biosciences’s investors?
Trilantic North America, MRM Capital, Tata Group, and Cycad Group have invested in Sofie Biosciences.
-
Who are Sofie Biosciences’s competitors?
Bamf Health and Alpha-9 Oncology are competitors of Sofie Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process